Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;9(1):1-8.
doi: 10.1007/s11552-013-9563-0.

Dupuytren's disease: current state of the art

Mark Henry  1
Affiliations
Review

Dupuytren's disease: current state of the art

Mark Henry. Hand (N Y). 2014 Mar.

Abstract

Background: This review article critically examines the current literature for Dupuytren's disease.

Methods: Five procedures are considered: dermofasciectomy, limited fasciectomy, segmental aponeurectomy, needle aponeurotomy, and collagenase injection. Studies regarding the efficacy of these treatments focus primarily on the initial degree of correction, rate of recurrence, and complications.

Results: No one treatment has been declared superior and substantial controversy exists. Comparison between studies has been hampered by the absence of uniform definitions for clinical success and measurable disease progression. Traditional post-operative care includes formal therapy and night splinting, but recent studies have questioned the value of these adjuncts.

Conclusion: The extent of involvement at which the surgeon should intervene was previously well accepted by convention, but as the paradigm shifts towards less invasive procedures, treatment may be offered at an earlier stage. Future research should be structured to recognize the value-based decision making used by patients when selecting treatment.

Keywords: Collagenase injection; Dermofasciectomy; Dupuytren's disease; Limited fasciectomy; Needle aponeurotomy; Segmental aponeurectomy.

PubMed Disclaimer

References

    1. Abe Y, Rokkaku T, Ofuchi W, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg (Br) 2004;29(5):427–430. doi: 10.1016/j.jhsb.2004.06.004. - DOI - PubMed
    1. Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren's disease. J Bone Joint Surg Br. 2000;82(1):90–94. doi: 10.1302/0301-620X.82B1.9808. - DOI - PubMed
    1. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg [Am] 2000;25(4):629–636. doi: 10.1053/jhsu.2000.6918. - DOI - PubMed
    1. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am] 2007;32(6):767–774. doi: 10.1016/j.jhsa.2007.04.002. - DOI - PubMed
    1. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg [Am] 2002;27(5):788–798. doi: 10.1053/jhsu.2002.35299. - DOI - PubMed

LinkOut - more resources